Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 — Nashville, Tennessee

Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000?

Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 conducted?

Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 has 1 clinical trials on record. Their work covers Breast Cancer.

Is Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 accredited by Crixeo Health?

Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.